HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Razac Selected Research

Vildagliptin

3/2007Vildagliptin in drug-naïve patients with type 2 diabetes: a 24-week, double-blind, randomized, placebo-controlled, multiple-dose study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Razac Research Topics

Disease

1Type 2 Diabetes Mellitus (MODY)
03/2007
1Hypoglycemia (Reactive Hypoglycemia)
03/2007
1Weight Gain
03/2007

Drug/Important Bio-Agent (IBA)

1VildagliptinIBA
03/2007